These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4008638)

  • 21. Humoral antibodies to acetylcholine receptor in patients with myasthenia gravis.
    Aharonov A; Abramsky O; Tarrab-Hazdai R; Fuchs S
    Lancet; 1975 Aug; 2(7930):340-2. PubMed ID: 51144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New antigen for antibody detection in myasthenia gravis.
    Gotti C; Mantegazza R; Clementi F
    Neurology; 1984 Mar; 34(3):374-7. PubMed ID: 6538281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naturally occurring anti-idiotypic antibodies in myasthenia gravis patients.
    Dwyer DS; Bradley RJ; Urquhart CK; Kearney JF
    Nature; 1983 Feb 17-23; 301(5901):611-4. PubMed ID: 6402708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An assessment of radioimmunoassay procedures for determination of anti-acetylcholine receptor antibodies in the sera of patients with myasthenia gravis.
    Carter B; Harrison R; Lunt GG; Morris H; Savage-Marengo T; Stephenson FA
    Ann Clin Biochem; 1981 May; 18(Pt 3):146-52. PubMed ID: 7283364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimuscle and antiacetylcholine receptor antibodies in myasthenia gravis.
    Penn AS; Schotland DL; Lamme S
    Muscle Nerve; 1986 Jun; 9(5):407-15. PubMed ID: 3724787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient-specific anti=acetylcholine receptor antibody patterns in myasthenia gravis.
    Savage-Marengo T; Harrison R; Lunt GG; Behan PO
    J Neurol Neurosurg Psychiatry; 1980 Apr; 43(4):316-20. PubMed ID: 7373331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features.
    Park KH; Waters P; Woodhall M; Lang B; Smith T; Sung JJ; Kim KK; Lim YM; Kim JE; Kim BJ; Park JS; Lim JG; Kim DS; Kwon O; Sohn EH; Bae JS; Yoon BN; Kim NH; Ahn SW; Oh J; Park HJ; Shin KJ; Hong YH
    PLoS One; 2018; 13(3):e0193723. PubMed ID: 29518096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum factor blocks neuromuscular transmission in myasthenia gravis: electrophysiologic study with intracellular microelectrodes.
    Shibuya N; Mori K; Nakazawa Y
    Neurology; 1978 Aug; 28(8):804-11. PubMed ID: 210423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spectrotypic analysis of antibodies to acetylcholine receptors in experimental autoimmune myasthenia gravis.
    Bionda A; De Baets MH; Tzartos SJ; Lindstrom JM; Weigle WO; Theophilopoulos AN
    Clin Exp Immunol; 1984 Jul; 57(1):41-50. PubMed ID: 6611231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphologic and immunopathologic findings in myasthenia gravis and in congenital myasthenic syndromes.
    Engel AG
    J Neurol Neurosurg Psychiatry; 1980 Jul; 43(7):577-89. PubMed ID: 6249893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of sera from myasthenia gravis patients and of alpha-bungarotoxin on acetylcholinesterase during in vitro neuromuscular synaptogenesis.
    de la Porte S; Ragueh F; Eymard B; Courbin P; Chapron J; Koenig J
    J Neurol Sci; 1993 Jul; 117(1-2):92-102. PubMed ID: 8410074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple forms of anti-acetylcholine receptor antibody in myasthenia gravis.
    Mittag T; Massa T; Kornfeld P; Papatestas A; Bender A; Genkins G
    Muscle Nerve; 1981; 4(1):16-25. PubMed ID: 6164920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies to the nicotinic acetylcholine receptor, obtained from serum of myasthenic patients, may decrease acetylcholine release from rat hippocampal nerve endings in vitro.
    Heilbronn E; Häggblad J; Kubát B
    Ann N Y Acad Sci; 1981; 377():198-207. PubMed ID: 6951473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of specific antibodies on acetylcholine receptor turnover: increased degradation controls low density of cell surface receptor.
    Sher E; Clementi F
    Neurology; 1984 Feb; 34(2):208-11. PubMed ID: 6538011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The immunopathology of myasthenia gravis.
    Lennon VA
    Hum Pathol; 1978 Sep; 9(5):541-51. PubMed ID: 309428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postoperative myasthenic crisis successfully treated with immunoadsorption therapy.
    Ishizeki J; Nishikawa K; Kunimoto F; Goto F
    J Anesth; 2005; 19(4):320-2. PubMed ID: 16261471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigen-specific apheresis of pathogenic autoantibodies from myasthenia gravis sera.
    Tzartos SJ; Bitzopoulou K; Gavra I; Kordas G; Jacobson L; Kostelidou K; Lagoumintzis G; Lazos O; Poulas K; Sideris S; Sotiriadis A; Trakas N; Zisimopoulou P
    Ann N Y Acad Sci; 2008; 1132():291-9. PubMed ID: 18567880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effect of myasthenic immunoglobulins against the lethal toxicity of alpha bungarotoxin.
    Vernet-der Garabedian B; Bach JF; Morel E
    Clin Exp Immunol; 1987 Apr; 68(1):130-7. PubMed ID: 3652512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human myasthenic sera reduce acetylcholine sensitivity of human muscle cells in tissue culture.
    Bevan S; Kullberg RW; Heinemann SF
    Nature; 1977 May; 267(5608):263-5. PubMed ID: 865619
    [No Abstract]   [Full Text] [Related]  

  • 40. Temporal correlation between serum CH
    Yanagidaira M; Nishida Y; Yokota T
    Clin Neurol Neurosurg; 2020 Feb; 189():105630. PubMed ID: 31830679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.